Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

787.04
+7.370.95%
Pre-market: 786.99-0.0500-0.01%06:09 EST
Volume:510.65K
Turnover:401.14M
Market Cap:83.21B
PE:18.92
High:792.16
Open:777.58
Low:777.58
Close:779.67
52wk High:821.11
52wk Low:476.49
Shares:105.72M
Float Shares:103.30M
Volume Ratio:0.73
T/O Rate:0.49%
Dividend:3.52
Dividend Rate:0.45%
EPS(TTM):41.59
EPS(LYR):41.48
ROE:14.87%
ROA:5.91%
PB:2.66
PE(LYR):18.97

Loading ...

Regeneron Director Huda Y. Zoghbi Disposes of Common Shares

Reuters
·
14 hours ago

BMO Capital Adjusts Price Target on Regeneron Pharmaceuticals to $900 From $850, Maintains Outperform Rating

MT Newswires Live
·
Feb 20

Garetosmab Biologics License Application Accepted For FDA Priority Review

Reuters
·
Feb 19

FDA accepts Regeneron’s garetosmab BLA for priority review in FOP

Reuters
·
Feb 19

Regeneron Pharmaceuticals Inc - FDA Decision Expected by August 2026

THOMSON REUTERS
·
Feb 19

Garetosmab Biologics License Application Accepted for FDA Priority Review for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP)

GlobeNewswire
·
Feb 19

Citi Reaffirms Their Buy Rating on Regeneron (REGN)

TIPRANKS
·
Feb 19

Regeneron Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Feb 18

Canaccord Genuity Reaffirms Their Buy Rating on Regeneron (REGN)

TIPRANKS
·
Feb 17

Ocular Therapeutix plunges as modest benefit overshadow trial win over Regeneron's Eylea

Reuters
·
Feb 17

Ocular Therapeutix's eye drug superior to Regeneron's Eylea in late-stage trial

Reuters
·
Feb 17

Regeneron Advances REGN7508 Into Phase 3 To Tackle Cancer-Linked Blood Clots

TIPRANKS
·
Feb 14

HSBC Adjusts Price Target on Regeneron Pharmaceuticals to $990 From $985, Maintains Buy Rating

MT Newswires Live
·
Feb 13

Sanofi Stock Near 52-Week Low As Leadership Shakeup Rattles Investors

Benzinga
·
Feb 13

Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant

Reuters
·
Feb 12

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 12

Regeneron Pharmaceuticals to Webcast Presentations at Major Healthcare Conferences

Reuters
·
Feb 12

Regeneron SVP Controller Jason Pitofsky Reports Disposal of Common Shares

Reuters
·
Feb 12

Regeneron Director Arthur F. Ryan Reports Sale of Common Shares

Reuters
·
Feb 12

Regeneron Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Feb 11